Dr David Littlejohn | Chris O'Brien Lifehouse
Dr David LittlejohnGeneral, Endocrine & Oncoplastic Surgeon

    Dr David Littlejohn

    General, Endocrine & Oncoplastic Surgeon



    Phone: (02) 6925 5488
    Fax: (02) 6925 1410
    Email: office@littlejohns.com.au


    • Breast and Oncoplastic Surgery

    Areas of Interest

    • Endoscopic and Laparoscopic Surgery
    • Flap-based Reconstructions

    Dr David Littlejohn is a specialist breast oncoplastic surgeon, performing a full range of breast cancer surgery and oncoplastic procedures including flap-based reconstructions. Dr Littlejohn is also a specialist endocrine, laparoscopic and general surgeon and is co-investigator at Riverina Cancer Care Centre for clinical trials.

    Littlejohn is past vice president of Breast Surgical Society of Australia and New Zealand and a founding member of Breast Surgeons NSW and BreastSurgANZ. He is the immediate past chair of the BreastSurgANZ Oncoplastic Committee. He convened the first Level 2 Cadaver oncoplastic workshop in Brisbane 2014 and has been involved in every BreastSurg ANZ workshop to date. He is a member of the International Society of Endocrine Surgeons and has recently published on minimally invasive parathyroid surgery and the use of 4DCT in Wagga and surgeon directed ultrasound.

    RACS; BreastSurgANZ;International Society of Endocrine Surgeons

    1. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01); A phase 3 randomised controlled trial. Vivian Galimberti; Bernard F Cole; Stefano Zurrida; Giuseppe Viale; Alberto Luini; Paolo Veronesi; Paola Baratella; Camelia Chifu; Manuela Sargenti; Mattia Intra, Oreste Gentilini, Mauro G Mastropasqua, Giovanni Mazzarol, Samuele Massarut, Jean-Remi Garbay, Janez Zgajnar, Hanne Galatius, Angelo Recalcati, David Littlejohn, Monika Bamert, Marco Colleoni, Karen N Price, Meredith M Regan, Aron Goldhirsch, Alan S Coates, Richard D Gelber, Umberto Veronesi, Lancet Oncol 2013 Apr 11;14(4);297-305. Epub 2013 Mar 11. Molecular Senology Unit, Senology Division, European Institute of Oncology, Milan Italy.

    2. Low Kenny “Littlejohn David R.G. “ The optimal number of sentinel nodes after intradermal injection of isotope and blue dye” ANZ journal of surgery 2006, vol. 76, no6, pp. 472-475

    3. Spillane AJ, Littlejohn D, Wong S, Robertson AO, Crowe P. Australia’s Breast Surgery Workload is Changing: Comparison of a Metropolitan and a Rural Hospital. Aust NZ J Surg 1999; 69;3:178-182.

    4. David R.G. Littlejohn, Graham L. Newstead. Tailored lateral sphincterotomy for anal fissure. Diseases of Colon & Rectum 1439-1442 vol40 no. 12 Dec, 1997

    1.A rural perspective on minimally invasive parathyroidectomy; optimal preoperative imaging and patient outcomes; Journal: ANZ Journal of Surgery.

    2.The Lancet Oncology; Title: Axillary dissection vs.no axillary dissection in patients with cT1-Ts cN0 M0 breast cancer and only micrometastases in sentinel nodes: ten year results of the IBCSG 23-01 Trial Corresponding Author: Meredith Regan; Co-Authors: Viviana Galimberti, MD; Bernard Cole: PhD; Giuseppe Viale, MD; Paolo Veronesi, MD; Elisa Vicini, MD,Mattia Taffurelli, MD; David Littlejohn, MBBS;Michael Knauer, MD, PhD; Carlo Tondini, MD; Angelo Di Leo, MD; Marco Coleoni, MD; Alan Coates, MD; Richard Gelber, PhD; Aron Goldhirsch,MD.

    Contact Us

    We're not around right now. But you can send us an email and we'll get back to you, asap.

    Not readable? Change text. captcha txt

    Start typing and press Enter to search